These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

268 related items for PubMed ID: 8894252

  • 1. Resistance to cytosine arabinoside by retrovirally mediated gene transfer of human cytidine deaminase into murine fibroblast and hematopoietic cells.
    Momparler RL, Eliopoulos N, Bovenzi V, Létourneau S, Greenbaum M, Cournoyer D.
    Cancer Gene Ther; 1996; 3(5):331-8. PubMed ID: 8894252
    [Abstract] [Full Text] [Related]

  • 2. Retroviral transfer and long-term expression of human cytidine deaminase cDNA in hematopoietic cells following transplantation in mice.
    Eliopoulos N, Bovenzi V, Le NL, Momparler LF, Greenbaum M, Létourneau S, Cournoyer D, Momparler RL.
    Gene Ther; 1998 Nov; 5(11):1545-51. PubMed ID: 9930308
    [Abstract] [Full Text] [Related]

  • 3. Selection of drug-resistant transduced cells with cytosine nucleoside analogs using the human cytidine deaminase gene.
    Beauséjour CM, Eliopoulos N, Momparler L, Le NL, Momparler RL.
    Cancer Gene Ther; 2001 Sep; 8(9):669-76. PubMed ID: 11593336
    [Abstract] [Full Text] [Related]

  • 4. [Mice transduced with double-mutant dihydrofolate reductase-cytidine deaminase fusion gene attained protection from high dose chemotherapy].
    Lu P, Lu Y, Pang K, Wang SB, Chen JQ, Xu HM, Wang JK, Zhao SC.
    Zhonghua Wai Ke Za Zhi; 2005 Aug 01; 43(15):998-1001. PubMed ID: 16194358
    [Abstract] [Full Text] [Related]

  • 5. Coexpression of rat glutathione S-transferase A3 and human cytidine deaminase by a bicistronic retroviral vector confers in vitro resistance to nitrogen mustards and cytosine arabinoside in murine fibroblasts.
    Létourneau S, Palerme JS, Delisle JS, Beauséjour CM, Momparler RL, Cournoyer D.
    Cancer Gene Ther; 2000 May 01; 7(5):757-65. PubMed ID: 10830723
    [Abstract] [Full Text] [Related]

  • 6. Human cytidine deaminase as an ex vivo drug selectable marker in gene-modified primary bone marrow stromal cells.
    Eliopoulos N, Al-Khaldi A, Beauséjour CM, Momparler RL, Momparler LF, Galipeau J.
    Gene Ther; 2002 Apr 01; 9(7):452-62. PubMed ID: 11938460
    [Abstract] [Full Text] [Related]

  • 7. Drug resistance to 5-aza-2'-deoxycytidine, 2',2'-difluorodeoxycytidine, and cytosine arabinoside conferred by retroviral-mediated transfer of human cytidine deaminase cDNA into murine cells.
    Eliopoulos N, Cournoyer D, Momparler RL.
    Cancer Chemother Pharmacol; 1998 Apr 01; 42(5):373-8. PubMed ID: 9771951
    [Abstract] [Full Text] [Related]

  • 8. Transfection of murine fibroblast cells with human cytidine deaminase cDNA confers resistance to cytosine arabinoside.
    Momparler RL, Laliberté J, Eliopoulos N, Beauséjour C, Cournoyer D.
    Anticancer Drugs; 1996 May 01; 7(3):266-74. PubMed ID: 8791999
    [Abstract] [Full Text] [Related]

  • 9. Coexpression of cytidine deaminase and mutant dihydrofolate reductase by a bicistronic retroviral vector confers resistance to cytosine arabinoside and methotrexate.
    Beauséjour CM, Le NL, Létourneau S, Cournoyer D, Momparler RL.
    Hum Gene Ther; 1998 Nov 20; 9(17):2537-44. PubMed ID: 9853520
    [Abstract] [Full Text] [Related]

  • 10. Gene amplification of human cytidine deaminase proviral cDNA and increased levels of its mRNA produces enhanced drug resistance to cytosine arabinoside in retroviral-transduced murine fibroblasts.
    Beauséjour CM, Momparler RL.
    Cancer Lett; 1999 Jan 08; 135(1):29-36. PubMed ID: 10077218
    [Abstract] [Full Text] [Related]

  • 11. Expression of a novel double-mutant dihydrofolate reductase-cytidine deaminase fusion gene confers resistance to both methotrexate and cytosine arabinoside.
    Sauerbrey A, McPherson JP, Zhao SC, Banerjee D, Bertino JR.
    Hum Gene Ther; 1999 Oct 10; 10(15):2495-504. PubMed ID: 10543614
    [Abstract] [Full Text] [Related]

  • 12. GATA1, cytidine deaminase, and the high cure rate of Down syndrome children with acute megakaryocytic leukemia.
    Ge Y, Stout ML, Tatman DA, Jensen TL, Buck S, Thomas RL, Ravindranath Y, Matherly LH, Taub JW.
    J Natl Cancer Inst; 2005 Feb 02; 97(3):226-31. PubMed ID: 15687366
    [Abstract] [Full Text] [Related]

  • 13. Constitutive overexpression of the cytidine deaminase gene confers resistance to cytosine arabinoside in vitro.
    Schröder JK, Kirch C, Flasshove M, Kalweit H, Seidelmann M, Hilger R, Seeber S, Schütte J.
    Leukemia; 1996 Dec 02; 10(12):1919-24. PubMed ID: 8946931
    [Abstract] [Full Text] [Related]

  • 14. Forced expression of cytidine deaminase confers resistance to cytosine arabinoside and gemcitabine.
    Neff T, Blau CA.
    Exp Hematol; 1996 Sep 02; 24(11):1340-6. PubMed ID: 8862446
    [Abstract] [Full Text] [Related]

  • 15. Recombinant gene products of two natural variants of the human cytidine deaminase gene confer different deamination rates of cytarabine in vitro.
    Kirch HC, Schröder J, Hoppe H, Esche H, Seeber S, Schütte J.
    Exp Hematol; 1998 May 02; 26(5):421-5. PubMed ID: 9590659
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Characterization of resistance to cytosine arabinoside (Ara-C) in NALM-6 human B leukemia cells.
    Kanno S, Hiura T, Ohtake T, Koiwai K, Suzuki H, Ujibe M, Ishikawa M.
    Clin Chim Acta; 2007 Feb 02; 377(1-2):144-9. PubMed ID: 17097625
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.